文献速递乳腺US乳腺X线

超声、乳腺X线摄影与组织病理学评估用于识别低核级别导管原位癌

US, Mammography, and Histopathologic Evaluation to Identify Low Nuclear Grade Ductal Carcinoma in Situ.
PubMed 文献 · Radiology · 2022-02-15

本回顾性研究纳入470例女性477个纯导管原位癌病灶,旨在建立术前模型识别低核级别导管原位癌。模型纳入超声表现为肿块且无微钙化、活检无粉刺坏死,验证集AUC达0.97(95%CI:0.94,1.00)。活检低核级别导管原位癌的升级率为38.8%(50/129),Ki-67阳性与持续低核级别呈负相关(OR=0.04,95%CI:0.0003,0.43,P=.005)。

要点

  • 超声表现为肿块且无微钙化、活检无粉刺坏死的病灶,术前模型识别低核级别DCIS的AUC为0.97。
  • 活检低核级别DCIS术后升级为中至高级别的比例为38.8%(50/129)。
  • Ki-67阳性与活检低核级别DCIS未升级为持续低核级别呈负相关(OR=0.04,P=.005)。

核心结论

  • 活检低核级别DCIS升级为中至高级别DCIS者超过三分之一;若超声表现为肿块且无微钙化、活检组织病理学无粉刺坏死,可识别最终病理为低核级别DCIS。

研究设计与样本

  • 回顾性研究,纳入2010年1月至2015年12月470例女性477个经手术组织病理学评估的纯DCIS病灶,中位年龄50岁(四分位距44-58岁),分为训练集330个和验证集147个,评估超声(肿块、非肿块)和乳腺X线摄影(形态特征、微钙化分布)特征。

关键影像表现/征象

  • 超声表现分为肿块型与非肿块型,乳腺X线摄影评估形态特征及微钙化分布。
  • 术前模型纳入超声表现为肿块且无微钙化、活检无粉刺坏死的病灶。

诊断标准与关键数值

  • 术前模型识别低核级别DCIS,验证集AUC为0.97(95%CI:0.94,1.00)。
  • 活检低核级别DCIS的升级率为38.8%(50/129)。
  • Ki-67阳性与持续低核级别DCIS的OR为0.04(95%CI:0.0003,0.43,P=.005)。

临床应用与阅片要点

  • 术前可结合超声表现(肿块、无微钙化)和活检组织病理学(无粉刺坏死)识别低核级别DCIS。
  • 活检低核级别DCIS需注意术后升级为中至高级别的可能,升级率为38.8%。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background Low nuclear grade ductal carcinoma in situ (DCIS) identified at biopsy can be upgraded to intermediate to high nuclear grade DCIS at surgery. Methods that confirm low nuclear grade are needed to consider nonsurgical approaches for these patients. Purpose To develop a preoperative model to identify low nuclear grade DCIS and to evaluate factors associated with low nuclear grade DCIS at biopsy that was not upgraded to intermediate to high nuclear grade DCIS at surgery. Materials and Methods In this retrospective study, 470 women (median age, 50 years; interquartile range, 44-58 years) with 477 pure DCIS lesions at surgical histopathologic evaluation were included (January 2010 to December 2015). Patients were divided into the training set (n = 330) or validation set (n = 147) to develop a preoperative model to identify low nuclear grade DCIS. Features at US (mass, nonmass) and at mammography (morphologic characteristics, distribution of microcalcification) were reviewed. The upgrade rate of low nuclear grade DCIS was calculated, and multivariable regression was used to evaluate factors for associations with low nuclear grade DCIS that was not upgraded later. Results A preoperative model that included lesions manifesting as a mass at US without microcalcification and no comedonecrosis at biopsy was used to identify low nuclear grade DCIS, with a high area under the receiver operating characteristic curve of 0.97 (95% CI: 0.94, 1.00) in the validation set. The upgrade rate of low nuclear grade DCIS at biopsy was 38.8% (50 of 129). Ki-67 positivity (odds ratio, 0.04; 95% CI: 0.0003, 0.43; P = .005) was inversely associated with constant low nuclear grade DCIS. Conclusion The upgrade rate of low nuclear grade ductal carcinoma in situ (DCIS) at biopsy to intermediate to high nuclear grade DCIS at surgery occurred in more than a third of patients; low nuclear grade DCIS at final histopathologic evaluation could be identified if the mass was viewed at US without microcalcifications and had no comedonecrosis at histopathologic evaluation of biopsy. © RSNA, 2022 Online supplemental material is available for this article. See also the editorial by Rahbar in this issue. An earlier incorrect version appeared online. This article was corrected on April 14, 2022.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Lee, Kim, Han, et al. US, Mammography, and Histopathologic Evaluation to Identify Low Nuclear Grade Ductal Carcinoma in Situ. Radiology. 2022. PMID: 35166586. doi:10.1148/radiol.211425

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。